Latest filing published 23 Jul 2024 for Eliem Therapeutics, Inc., €332k. Read the official filing
This profile gathers the share dealings of Valerie Morisset in Climb Bio, Inc. The record holds 13 filings, for trades running from 10 March 2023 to 22 July 2024.
The open-market record consists of 9 sales worth €1.7M, with no purchase. Besides market trades, the filings include 4 option exercises. Since January 2024: no purchases and 9 sales on the market.
Most recently, on 23 July 2024, the filings show an open-market sale worth €289k in Climb Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations